Press Release
DuploCloud Has Joined the Startup Perks Program From Google Cloud, Where It Provides Exclusive Benefits to Startups on Its DevOps AI Platform
Eligible Startups Can Access DuploCloud Through Google Cloud's Startup Perk Program to Help Simplify Cloud Operations, Security, Compliance and Infrastructure Management Read More
Press Release
Electrovaya Launches ElvaPulse(TM) 1500 High-Power Energy Storage Platform for Data Center and Mission-Critical Power Applications
Offering nearly 3 MWh of energy with up to 7 MW of continuous power for demanding data center, AI infrastructure and critical-power applications Initial deliveries targeted for Q2 2027 from Electrovaya's Jamestown, NY manufacturing facility, designed to support 48E Investment Tax Credit eligibility Read More
Press Release
UNICO National Celebrates Landmark 103rd Annual Convention and Italian American Awards Gala Honoring Leadership, Service, and the American Dream
HPE CEO Antonio Neri Receives Lifetime Achievement Award as Organization Welcomes New Leadership and Looks Ahead to Nashville in 2027 Read More
Press Release
Worksport Announces Q2 2026 Earnings Call and Investor Town Hall for August 11, 2026; CEO Believes Current Market Valuation Does Not Yet Fully Reflect Recent Positive Operating Progress
Worksport will host its Q2 2026 earnings conference call on August 11, 2026, at 4:30 p.m. ET, following market close, with an investor townhall immediately afterward featuring CEO commentary, business updates, and shareholder Q&A. Read More
Press Release
Vanta Commends U.S. FDA Advisory Committee Vote Recommending Inclusion of Six Peptide Substances on FDA's 503A Bulks List, Including BPC-157, TB-500 and MOTS-c
News Release Highlights: U.S. FDA Pharmacy Compounding Advisory Committee recommends the inclusion of six peptide substances, including BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax, on the FDA's 503A Bulks List, representing a significant step in the FDA's ongoing regulatory review process for these peptide substances. Vanta has established a strategic operating framework supporting its contemplated U.S. peptide platform, including telehealth-enabled commercialization, FDA-registered compounding pharmacy coordination, peptide manufacturing and fulfillment capabilities, and compliant payment processing infrastructure. Vanta continues advancing its strategy to build an integrated U.S.-focused consumer health sciences platform combining contemplated peptide therapies with its existing nutraceutical and premium functional hydration portfolio, positioning the Company to participate in the longevity and preventative wellness market. Read More
Press Release
Jaguar Health Reports Positive Consumer and Veterinary Market Research Findings Supporting Commercial Opportunity for Neonorm Dog
Neonorm® Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool consistency and GI fluid balance in dogs Jaguar expects to make Neonorm Dog available through both Amazon and Chewy Read More
Press Release
Sekur Private Data Reports 25% Month-Over-Month Increase in Average Revenue Per User as Premium Pivot Takes Hold
Premium pivot to HNWI, C-level and government clients is replacing legacy users with subscribers paying up to 10X more - ARPU expected to keep climbing as SekurOne launches at US$300/month, with full profitability targeted at 200 users generating US$60,000 per month Read More
Press Release
30 June 2026 Quarterly Activities Report
Highlights Challenger Gold Project, SA (100%) Drilling confirms new high-grade mineralisation up to 170g/t Au in ‘main' pit (read), up to 60g/t Au at Challenger West (read), new open pittable mineralisation at CSSW and Challenger 3 (read) Definitive Feasibility Study (DFS) ongoing; existing mill suitable for recommissioning, scenario analyses now underway (read) JORC Mineral Resources Estimate (MRE) update pending; Barton targeting DFS publication during Q1 CY 2027 Tunkillia Gold Project, SA (100%) ‘Phase 2' upgrade drilling yields highest-grade assays to-date from ‘Area 51' zone (read) and southern ‘Area 223' zone (read), indicating potential growth in Resources, open pit and mine life ‘Phase 2' reverse circulation (RC) drilling expanded to ~40,000m following analysis of ‘Phase 1' and ‘Phase 2' results to-date (read), with ~3,000m dual rig diamond drilling (DD) commenced (read) Read More
Press Release
